CVE-2022-46355CWE-200

A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC…

High · published December 13, 2022

CVSS v3.1
7.5
EPSS
1%
Percentile
50.2
In the wild
Unconfirmed
What it is

A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.

The record
Technical detail
CVSS v3.1
7.5 · HIGH
Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS v4.0
Not supplied
EPSS
0.00644 · 50.2th percentile
Weakness
CWE-200 · Exposure of Sensitive Information to an Unauthorized Actor
Published
2022-12-13T00:00Z
EPSS history
Timeline
  • 13 DEC 00:00Z
    A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC…
    cvelistv5